Disease Areas:
Cough, Lung cancerDevice Types:
VitaloJAKDOI:
10.4046/trd.2025.0166This review examined the mechanisms, assessment, and stepwise management of cough in patients with lung cancer, including postoperative and refractory cough. The VitaloJAK cough monitor was used in a cited clinical trial to objectively measure awake, sleep, and 24-hour cough frequency when evaluating the antitussive effects of aprepitant.
